ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645931; 2) Community: the network communities that were significantly associated with the response to NSC 645931; 3) Molecule: the relationships between components within communities and NSC 645931; 4) MDR: the compounds that were significantly associated with the NSC 645931.

NSC Compound Enrichment Correlation
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0434721470609156 -0.038214727
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0434721470609156 0.12797035
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0434721470609156 0.081617565
NSC 176503 Fastigilin B 0.0434721470609156 0.13912863
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0434721470609156 0.17518931
NSC 24030 p-Phenylenediamine (8CI), N-butyl-N'-phenyl- 0.0434721470609156 0.13196593
NSC 266491 Psorspermin 0.0434721470609156 0.0027095585
NSC 295501 Camptothecin Derivative 0.0434721470609156 -0.18277976
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0434721470609156 0.010381749
NSC 32937 Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride 0.0434721470609156 0.083412663
Total:73  Current:67    [First] [Prev] [Next] [Last]